Document Detail


Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds.
MedLine Citation:
PMID:  18310985     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nattokinase is used as a health-promoting medicine for preventing thrombosis due to its fibrinolytic activity. Cerebral microbleed is remnant of blood extravasations from the damaged vessels related to cerebral microangiopathies. We report a patient, having used aspirin for secondary stroke prevention, who had an acute cerebellar hemorrhage after taking nattokinase 400 mg daily for 7 consecutive days. In addition to the hemorrhagic lesion, multiple microbleeds were demonstrated on brain MR images. We suggest that nattokinase may increase risk of intracerebral hemorrhage in patients who have bleeding-prone cerebral microangiopathy and are receiving other antithrombotic agent at the same time.
Authors:
Yung-Yee Chang; Jia-Shou Liu; Shung-Lon Lai; Hsiu-Shan Wu; Min-Yu Lan
Related Documents :
9632185 - Regional cerebral blood volume after severe head injury in patients with regional cereb...
10372845 - Primary antiphospholipid syndrome and cerebral atrophy: a rare association?
10702445 - The effects of remifentanil on cerebral capacity in awake volunteers.
3041565 - The concept of inner cerebral trauma.
9574615 - Three-dimensional volumetric assessment of abnormally low attenuation of the lung from ...
17295615 - Evaluation of quantitative magnetic resonance imaging contrasts in mri-negative refract...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-03-03
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  47     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2008  
Date Detail:
Created Date:  2008-03-03     Completed Date:  2008-03-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  467-9     Citation Subset:  IM    
Affiliation:
Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aspirin / adverse effects*
Diffusion Magnetic Resonance Imaging
Female
Fibrinolytic Agents / adverse effects*
Herb-Drug Interactions*
Humans
Intracranial Hemorrhages / chemically induced*,  radiography
Ischemic Attack, Transient / prevention & control
Middle Aged
Plant Extracts / adverse effects
Platelet Aggregation Inhibitors / adverse effects*
Self Medication / adverse effects*
Stroke / complications
Subtilisins / adverse effects*
Thrombosis / prevention & control
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Plant Extracts; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; EC 3.4.21.-/Subtilisins; EC 3.4.21.-/nattokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion.
Next Document:  [Assessment of the utility of digital subtraction in lacrimal passage contrasting].